Lymphovascular invasion in hormone-positive, human epidermal growth factor-negative, low-burden axillary disease in early breast cancer patients tested for oncotype DX recurrence score

INTRODUCTION: The oncotype DX recurrence score (ODX-RS) is a validated 21-gene assay that can quantify the recurrence risk and assess the likelihood of adjuvant chemotherapy benefit in breast cancer. The presence of lymphovascular invasion (LVI) in breast cancer patients is regarded as a predictor f...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Zawi, Abdalla Saad Abdalla, Yin, Su Lei, Aladili, Zina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319188/
https://www.ncbi.nlm.nih.gov/pubmed/35903213
http://dx.doi.org/10.5114/wo.2022.118220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319188/
https://www.ncbi.nlm.nih.gov/pubmed/35903213
http://dx.doi.org/10.5114/wo.2022.118220

Ejemplares similares